List of Tables
Table 1. Global Retinal Degenerative Disease Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Retinal Degenerative Disease Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Retinal Degenerative Disease Treatment Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Retinal Degenerative Disease Treatment Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Retinal Degenerative Disease Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Retinal Degenerative Disease Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Retinal Degenerative Disease Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Retinal Degenerative Disease Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Degenerative Disease Treatment Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Retinal Degenerative Disease Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Retinal Degenerative Disease Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Retinal Degenerative Disease Treatment Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Retinal Degenerative Disease Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Retinal Degenerative Disease Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Retinal Degenerative Disease Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Retinal Degenerative Disease Treatment Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Retinal Degenerative Disease Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Retinal Degenerative Disease Treatment Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Retinal Degenerative Disease Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Retinal Degenerative Disease Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Retinal Degenerative Disease Treatment Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Retinal Degenerative Disease Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Retinal Degenerative Disease Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Retinal Degenerative Disease Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Retinal Degenerative Disease Treatment Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Retinal Degenerative Disease Treatment Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Retinal Degenerative Disease Treatment Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Retinal Degenerative Disease Treatment Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Retinal Degenerative Disease Treatment Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Retinal Degenerative Disease Treatment Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Retinal Degenerative Disease Treatment Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Retinal Degenerative Disease Treatment Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Retinal Degenerative Disease Treatment Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Retinal Degenerative Disease Treatment Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Retinal Degenerative Disease Treatment Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Retinal Degenerative Disease Treatment Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Retinal Degenerative Disease Treatment Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Regeneron Pharmaceuticals Company Information
Table 71. Regeneron Pharmaceuticals Description and Business Overview
Table 72. Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Product
Table 74. Regeneron Pharmaceuticals Recent Developments/Updates
Table 75. Bayer HealthCare Company Information
Table 76. Bayer HealthCare Description and Business Overview
Table 77. Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Product
Table 79. Bayer HealthCare Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Retinal Degenerative Disease Treatment Drugs Product
Table 84. Novartis Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Roche Retinal Degenerative Disease Treatment Drugs Product
Table 89. Roche Recent Developments/Updates
Table 90. Kanghong Pharma Company Information
Table 91. Kanghong Pharma Description and Business Overview
Table 92. Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Product
Table 94. Kanghong Pharma Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck Retinal Degenerative Disease Treatment Drugs Product
Table 99. Merck Recent Developments/Updates
Table 100. Takeda Company Information
Table 101. Takeda Description and Business Overview
Table 102. Takeda Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Takeda Retinal Degenerative Disease Treatment Drugs Product
Table 104. Takeda Recent Developments/Updates
Table 105. Valeant Pharmaceuticals International，Inc Company Information
Table 106. Valeant Pharmaceuticals International，Inc Description and Business Overview
Table 107. Valeant Pharmaceuticals International，Inc Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Valeant Pharmaceuticals International，Inc Retinal Degenerative Disease Treatment Drugs Product
Table 109. Valeant Pharmaceuticals International，Inc Recent Developments/Updates
Table 110. Oxurion（ThromboGenics） Company Information
Table 111. Oxurion（ThromboGenics） Description and Business Overview
Table 112. Oxurion（ThromboGenics） Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Oxurion（ThromboGenics） Retinal Degenerative Disease Treatment Drugs Product
Table 114. Oxurion（ThromboGenics） Recent Developments/Updates
Table 115. Santen Pharmaceutical Company Information
Table 116. Santen Pharmaceutical Description and Business Overview
Table 117. Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Product
Table 119. Santen Pharmaceutical Recent Developments/Updates
Table 120. jCyte, Inc. Company Information
Table 121. jCyte, Inc. Description and Business Overview
Table 122. jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Product
Table 124. jCyte, Inc. Recent Developments/Updates
Table 125. Kodiak Sciences Company Information
Table 126. Kodiak Sciences Description and Business Overview
Table 127. Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Product
Table 129. Kodiak Sciences Recent Developments/Updates
Table 130. Coherus BioSciences, Inc Company Information
Table 131. Coherus BioSciences, Inc Description and Business Overview
Table 132. Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Product
Table 134. Coherus BioSciences, Inc Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Retinal Degenerative Disease Treatment Drugs Distributors List
Table 138. Retinal Degenerative Disease Treatment Drugs Customers List
Table 139. Retinal Degenerative Disease Treatment Drugs Market Trends
Table 140. Retinal Degenerative Disease Treatment Drugs Market Drivers
Table 141. Retinal Degenerative Disease Treatment Drugs Market Challenges
Table 142. Retinal Degenerative Disease Treatment Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Retinal Degenerative Disease Treatment Drugs
Figure 2. Global Retinal Degenerative Disease Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Retinal Degenerative Disease Treatment Drugs Market Share by Type: 2024 & 2031
Figure 4. Age Related Macular Degeneration (AMD) Treatment Drug Product Picture
Figure 5. Retinitis Pigmentosa (RP) Treatment Drug Product Picture
Figure 6. Global Retinal Degenerative Disease Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Retinal Degenerative Disease Treatment Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Retinal Degenerative Disease Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Retinal Degenerative Disease Treatment Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Retinal Degenerative Disease Treatment Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Retinal Degenerative Disease Treatment Drugs Average Price (US$/Unit) & (2020-2031)
Figure 15. Retinal Degenerative Disease Treatment Drugs Report Years Considered
Figure 16. Retinal Degenerative Disease Treatment Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Retinal Degenerative Disease Treatment Drugs Players: Market Share by Revenue in Retinal Degenerative Disease Treatment Drugs in 2024
Figure 19. Retinal Degenerative Disease Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Retinal Degenerative Disease Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Retinal Degenerative Disease Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 23. United States Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Retinal Degenerative Disease Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Retinal Degenerative Disease Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 42. Latin America Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Retinal Degenerative Disease Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Retinal Degenerative Disease Treatment Drugs by Type (2020-2031)
Figure 52. Global Revenue Market Share of Retinal Degenerative Disease Treatment Drugs by Type (2020-2031)
Figure 53. Global Retinal Degenerative Disease Treatment Drugs Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Retinal Degenerative Disease Treatment Drugs by Application (2020-2031)
Figure 55. Global Revenue Market Share of Retinal Degenerative Disease Treatment Drugs by Application (2020-2031)
Figure 56. Global Retinal Degenerative Disease Treatment Drugs Price (US$/Unit) by Application (2020-2031)
Figure 57. Retinal Degenerative Disease Treatment Drugs Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
